These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1805576)

  • 1. Common sequence in HIV 1 GP41 and HLA class II beta chains can generate crossreactive autoantibodies with immunosuppressive potential early in the course of HIV 1 infection.
    Blackburn R; Clerici M; Mann D; Lucey DR; Goedert J; Golding B; Shearer GM; Golding H
    Adv Exp Med Biol; 1991; 303():63-9. PubMed ID: 1805576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.
    Golding H; Shearer GM; Hillman K; Lucas P; Manischewitz J; Zajac RA; Clerici M; Gress RE; Boswell RN; Golding B
    J Clin Invest; 1989 Apr; 83(4):1430-5. PubMed ID: 2467924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.
    Golding H; Robey FA; Gates FT; Linder W; Beining PR; Hoffman T; Golding B
    J Exp Med; 1988 Mar; 167(3):914-23. PubMed ID: 3127528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to MHC class II peptides are present in HIV-1-positive sera.
    Zaitseva MB; Moshnikov SA; Kozhich AT; Frolova HA; Makarova OD; Pavlikov SP; Sidorovich IG; Brondz BB
    Scand J Immunol; 1992 Mar; 35(3):267-73. PubMed ID: 1535985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I infected individuals.
    Dis Markers; 1990; 8(3):165-6. PubMed ID: 1703062
    [No Abstract]   [Full Text] [Related]  

  • 7. The Mycoplasma genitalium adhesin protein and several human class II MHC proteins exhibit sequence homology: possible ramifications for the development of autoimmunity.
    Bisset LR
    Autoimmunity; 1992; 14(2):167-8. PubMed ID: 1303682
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of antibodies to HIV-1 gp41- and HLA class II antigen-derived peptides in SLE patients.
    Koshino K; Tokano Y; Hishikawa T; Sekigawa I; Takasaki Y; Hashimoto H
    Scand J Rheumatol; 1995; 24(5):288-92. PubMed ID: 8533043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lymphocyte antibodies in plasma of HIV-1-infected patients preferentially react with MHC class II-negative T cells and are linked to antibodies against gp41.
    Müller C; Kukel S; Schneweis KE; Bauer R
    Clin Exp Immunol; 1994 Sep; 97(3):367-72. PubMed ID: 8082291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.
    Johnson RP; Trocha A; Buchanan TM; Walker BD
    J Exp Med; 1992 Apr; 175(4):961-71. PubMed ID: 1372650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41.
    Rey-Cuillé MA; Svab J; Benferhat R; Krust B; Briand JP; Muller S; Hovanessian AG
    J Pharm Pharmacol; 2006 Jun; 58(6):759-67. PubMed ID: 16734977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of immunodeficiency in HIV infection and ways of overcoming it].
    Brondz BD; Zaĭtseva MB; Kozhich AT; Moshnikov SA; Makarova OD; Frolova EA
    Genetika; 1992 Jul; 28(7):19-26. PubMed ID: 1427054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of immune suppression by a synthetic HIV gp41 peptide.
    Wang H; Nishanian P; Fahey JL
    Cell Immunol; 1995 Apr; 161(2):236-43. PubMed ID: 7697734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.
    Bell SJ; Cooper DA; Kemp BE; Doherty RR; Penny R
    Clin Exp Immunol; 1992 Jan; 87(1):37-45. PubMed ID: 1370773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.
    Ugen KE; Srikantan V; Goedert JJ; Nelson RP; Williams WV; Weiner DB
    J Infect Dis; 1997 Jan; 175(1):63-9. PubMed ID: 8985197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of anti-gp41 core structure antibodies, which compete with sera of HIV-1-infected patients.
    Usami O; Xiao P; Ling H; Liu Y; Nakasone T; Hattori T
    Microbes Infect; 2005 Apr; 7(4):650-7. PubMed ID: 15823513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-mediated enhancement of HIV-1 neutralisation by anti-HLA antibodies derived from polytransfused patients.
    Wilfingseder D; Spruth M; Ammann CG; Döpper S; Speth C; Dierich MP; Stoiber H
    Int Arch Allergy Immunol; 2003 May; 131(1):62-72. PubMed ID: 12759492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.